Literature DB >> 14736947

Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia: here are we now and where do we go from here?

Francesco Locatelli, Pedro Aljama, Peter Barany, Bernard Canaud, Fernando Carrera, Kai-Uwe Eckardt, Iain C Macdougall, Alison Macleod, Walter H Hörl, Andrzej Wiecek, Stewart Cameron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14736947     DOI： 10.1093/ndt/gfg489

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

1.  Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies.

Authors:  John Ferbas; John Thomas; John Hodgson; Amitabh Gaur; Nicole Casadevall; Steven J Swanson
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

Review 2.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 3.  Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Pure red cell aplasia after treatment of renal anaemia with epoetin theta.

Authors:  W Herrington; Clemens Wieser; Alexander R Rosenkranz
Journal:  Clin Kidney J       Date:  2013-08-13

5.  Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.

Authors:  Patrícia Garrido; Sandra Ribeiro; João Fernandes; Helena Vala; Elsa Bronze-da-Rocha; Petronila Rocha-Pereira; Luís Belo; Elísio Costa; Alice Santos-Silva; Flávio Reis
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.

Authors:  Patrícia Garrido; Sandra Ribeiro; João Fernandes; Helena Vala; Petronila Rocha-Pereira; Elsa Bronze-da-Rocha; Luís Belo; Elísio Costa; Alice Santos-Silva; Flávio Reis
Journal:  Int J Mol Sci       Date:  2015-12-25       Impact factor: 5.923

7.  Recombinant human epoetin beta in the treatment of renal anemia.

Authors:  Francesco Locatelli; Pietro Pozzoni; Lucia Del Vecchio
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

8.  Design and Evaluation of a Multiplexed Assay to Assess Human Immunogenicity Against Humira®.

Authors:  Matthew Alleyn; Kristin Closson; Adam Gentile; Nathan Gulbis; Christopher Taylor; Paul Rhyne
Journal:  AAPS J       Date:  2020-08-03       Impact factor: 4.009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.